SCIANDRA, MARIKA
SCIANDRA, MARIKA
CENTRO INTERDIPARTIMENTALE ALMA MATER INSTITUTE ON HEALTHY PLANET
Personale esterno ed autonomi
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
2020 Sciandra M.; De Feo A.; Parra A.; Landuzzi L.; Lollini P.-L.; Manara M.C.; Mattia G.; Pontecorvi G.; Baricordi C.; Guerzoni C.; Bazzocchi A.; Longhi A.; Scotlandi K.
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation
2019 De Feo A.; Sciandra M.; Ferracin M.; Felicetti F.; Astolfi A.; Pignochino Y.; Picci P.; Care A.; Scotlandi K.
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.
2014 Sciandra M;Marino MT;Manara MC;Guerzoni C;Grano M;Oranger A;Lucarelli E;Lollini PL;Dozza B;Pratelli L;Renzo MF;Colombo MP;Picci P;Scotlandi K
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity.
2014 Zucchini C;Manara MC;Pinca RS;De Sanctis P;Guerzoni C;Sciandra M;Lollini PL;Cenacchi G;Picci P;Valvassori L;Scotlandi K
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation while its deficiency favors myeloid cell expansion
2012 Tripodo, Claudio; Sangaletti, Sabina; Guarnotta, Carla; Piccaluga, Pier P; Cacciatore, Matilde; Giuliano, Michela; Franco, Giovanni; Chiodoni, Claudia; Sciandra, Marika; Miotti, Silvia; Others,
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity
2007 Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P
CD99 Acts as an Oncosuppressor in Osteosarcoma.
2006 Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.; Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma | Sciandra M.; De Feo A.; Parra A.; Landuzzi L.; Lollini P.-L.; Manara M.C.; Mattia G.; Pontecorvi ...G.; Baricordi C.; Guerzoni C.; Bazzocchi A.; Longhi A.; Scotlandi K. | 2020-01-01 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | - |
| Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation | De Feo A.; Sciandra M.; Ferracin M.; Felicetti F.; Astolfi A.; Pignochino Y.; Picci P.; Care A.; ...Scotlandi K. | 2019-01-01 | CELL DEATH & DISEASE | - | 1.01 Articolo in rivista | s41419-019-1675-1.pdf |
| CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. | Sciandra M;Marino MT;Manara MC;Guerzoni C;Grano M;Oranger A;Lucarelli E;Lollini PL;Dozza B;Pratel...li L;Renzo MF;Colombo MP;Picci P;Scotlandi K | 2014-01-01 | JOURNAL OF BONE AND MINERAL RESEARCH | - | 1.01 Articolo in rivista | - |
| CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. | Zucchini C;Manara MC;Pinca RS;De Sanctis P;Guerzoni C;Sciandra M;Lollini PL;Cenacchi G;Picci P;Va...lvassori L;Scotlandi K | 2014-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation while its deficiency favors myeloid cell expansion | Tripodo, Claudio; Sangaletti, Sabina; Guarnotta, Carla; Piccaluga, Pier P; Cacciatore, Matilde; G...iuliano, Michela; Franco, Giovanni; Chiodoni, Claudia; Sciandra, Marika; Miotti, Silvia; Others, | 2012-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity | Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni ...P; Lollini PL; Bernard A; Picci P | 2007-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| CD99 Acts as an Oncosuppressor in Osteosarcoma. | Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.;... Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K. | 2006-01-01 | MOLECULAR BIOLOGY OF THE CELL | - | 1.01 Articolo in rivista | - |